| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |